by University of Bergen Duration of migraine preventive treatment by drug group. (a) Proportion of patients still on preventive migraine therapy after 90, 180, 270, and 360 days and proportion of patients still on each drug since first prescription (retention rate). (b) Retention rate with 95% confidence intervals (dotted lines) adjusted for patient characteristics, comorbidities, year of...
